"Acinetobacter Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infections with bacteria of the genus ACINETOBACTER.
Descriptor ID |
D000151
|
MeSH Number(s) |
C01.252.400.560.022
|
Concept/Terms |
Acinetobacter Infections- Acinetobacter Infections
- Mimae Infections
- Infections, Mimae
- Infection, Mimae
- Mimae Infection
- Infections, Acinetobacter
- Acinetobacter Infection
- Infection, Acinetobacter
|
Below are MeSH descriptors whose meaning is more general than "Acinetobacter Infections".
Below are MeSH descriptors whose meaning is more specific than "Acinetobacter Infections".
This graph shows the total number of publications written about "Acinetobacter Infections" by people in this website by year, and whether "Acinetobacter Infections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2014 | 0 | 2 | 2 |
2015 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Acinetobacter Infections" by people in Profiles.
-
Shrihari S, May HC, Yu JJ, Papp SB, Chambers JP, Guentzel MN, Arulanandam BP. Thioredoxin-mediated alteration of protein content and cytotoxicity of Acinetobacter baumannii outer membrane vesicles. Exp Biol Med (Maywood). 2022 02; 247(3):282-288.
-
May HC, Yu JJ, Zhang H, Wang Y, Cap AP, Chambers JP, Guentzel MN, Arulanandam BP. Thioredoxin-A is a virulence factor and mediator of the type IV pilus system in Acinetobacter baumannii. PLoS One. 2019; 14(7):e0218505.
-
Ainsworth S, Ketter PM, Yu JJ, Grimm RC, May HC, Cap AP, Chambers JP, Guentzel MN, Arulanandam BP. Vaccination with a live attenuated Acinetobacter baumannii deficient in thioredoxin provides protection against systemic Acinetobacter infection. Vaccine. 2017 06 08; 35(26):3387-3394.
-
Martinez T, Martinez I, Vazquez GJ, Aquino EE, Robledo IE. Genetic environment of the KPC gene in Acinetobacter baumannii ST2 clone from Puerto Rico and genomic insights into its drug resistance. J Med Microbiol. 2016 Aug; 65(8):784-792.
-
Ou HY, Kuang SN, He X, Molgora BM, Ewing PJ, Deng Z, Osby M, Chen W, Xu HH. Complete genome sequence of hypervirulent and outbreak-associated Acinetobacter baumannii strain LAC-4: epidemiology, resistance genetic determinants and potential virulence factors. Sci Rep. 2015 Mar 02; 5:8643.
-
Mart?nez T, V?zquez GJ, Aquino EE, Mart?nez I, Robledo IE. ISEcp1-mediated transposition of blaKPC into the chromosome of a clinical isolate of Acinetobacter baumannii from Puerto Rico. J Med Microbiol. 2014 Dec; 63(Pt 12):1644-1648.
-
Ketter PM, Guentzel MN, Schaffer B, Herzig M, Wu X, Montgomery RK, Parida BK, Fedyk CG, Yu JJ, Jorgensen J, Chambers JP, Cap AP, Arulanandam BP. Severe Acinetobacter baumannii sepsis is associated with elevation of pentraxin 3. Infect Immun. 2014 Sep; 82(9):3910-8.
-
Dent LL, Marshall DR, Pratap S, Hulette RB. Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital. BMC Infect Dis. 2010 Jul 07; 10:196.
-
Robledo IE, Aquino EE, Sant? MI, Santana JL, Otero DM, Le?n CF, V?zquez GJ. Detection of KPC in Acinetobacter spp. in Puerto Rico. Antimicrob Agents Chemother. 2010 Mar; 54(3):1354-7.